241 related articles for article (PubMed ID: 53065)
1. Serum inhibitors in fibrinolysis.
Gallimore MJ
Br J Haematol; 1975 Oct; 31(2):217-31. PubMed ID: 53065
[TBL] [Abstract][Full Text] [Related]
2. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
Müllertz S
Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.
Moroi M; Aoki N
J Biol Chem; 1976 Oct; 251(19):5956-65. PubMed ID: 134998
[TBL] [Abstract][Full Text] [Related]
4. Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma.
Clemmensen I; Thorsen S; Müllertz S
Haemostasis; 1976; 5(4):218-30. PubMed ID: 826461
[TBL] [Abstract][Full Text] [Related]
5. The behavior of alpha2-plasmin inhibitor in fibrinolytic states.
Aoki N; Moroi M; Matsuda M; Tachiya K
J Clin Invest; 1977 Aug; 60(2):361-9. PubMed ID: 68962
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of trypsin, chymotrypsin and elastase inhibitors in porcine serum.
Weström BR
Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1869-78. PubMed ID: 93564
[TBL] [Abstract][Full Text] [Related]
7. Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.
Aoki N; Moroi M; Tachiya K
Thromb Haemost; 1978 Feb; 39(1):22-31. PubMed ID: 77050
[TBL] [Abstract][Full Text] [Related]
8. Studies on the activation mechanism of fibrinolytic enzyme system in plasma by human pancreatic elastase.
Toki N; Takasugi S; Ishizu K; Sato H; Sumi H
Thromb Haemost; 1982 Feb; 47(1):8-13. PubMed ID: 6176043
[TBL] [Abstract][Full Text] [Related]
9. Reaction of thrombin and proteinases of the fibrinolytic system with a mechanism-based inhibitor, 3,4-dihydro-3-benzyl-6-chloromethylcoumarin.
Mor A; Maillard J; Favreau C; Reboud-Ravaux M
Biochim Biophys Acta; 1990 Mar; 1038(1):119-24. PubMed ID: 2138500
[TBL] [Abstract][Full Text] [Related]
10. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma.
Collen D
Eur J Biochem; 1976 Oct; 69(1):209-16. PubMed ID: 136345
[TBL] [Abstract][Full Text] [Related]
11. Production of the modified form of human plasminogen by alpha 2-macroglobulin-plasmin complexes.
Yamamoto J; Okamoto U; Morita S; Asada N; Yamaoka M
Jpn J Physiol; 1985; 35(6):1013-21. PubMed ID: 2422420
[TBL] [Abstract][Full Text] [Related]
12. Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexes.
Harpel PC; Mosesson MW
J Clin Invest; 1973 Sep; 52(9):2175-84. PubMed ID: 4269529
[TBL] [Abstract][Full Text] [Related]
13. Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors.
Kolev K; Komorowicz E; Machovich R
Blood Coagul Fibrinolysis; 1994 Dec; 5(6):905-11. PubMed ID: 7534486
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of urokinase by complex formation with human alpha1-antitrypsin.
Clemmensen I; Christensen F
Biochim Biophys Acta; 1976 Apr; 429(2):591-9. PubMed ID: 1083251
[TBL] [Abstract][Full Text] [Related]
15. Proceedings: Influence of plasmin inhibitors on differentiating digestion between fibrinogenolysis and fibrinolysis.
Abe T; Kazama M
Thromb Diath Haemorrh; 1975 Nov; 34(2):584. PubMed ID: 53895
[No Abstract] [Full Text] [Related]
16. New neonatal problems of blood coagulation and fibrinolysis. I. The change of plasmin inhibitor levels in the newborn infant.
Suzuki S; Wake N; Yoshiaki K
J Perinat Med; 1976; 4(4):213-20. PubMed ID: 64604
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen-plasmin system. VI. Preparation of alpha 2-macroglobulin antiplasmin from human plasma.
Iwamoto M; Abiko Y
Biochim Biophys Acta; 1970 Sep; 214(3):402-10. PubMed ID: 4251763
[No Abstract] [Full Text] [Related]
18. The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl)carbamoylimidazole.
Walker B; Elmore DT
Biochem J; 1984 Jul; 221(1):277-80. PubMed ID: 6235806
[TBL] [Abstract][Full Text] [Related]
19. Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors.
Kolev K; Léránt I; Tenekejiev K; Machovich R
J Biol Chem; 1994 Jun; 269(25):17030-4. PubMed ID: 7516329
[TBL] [Abstract][Full Text] [Related]
20. Separation of two new trypsin-inhibiting fractions from human serum.
Nowak S; Bieth J; Miesch F
Enzyme; 1975; 20(2):71-9. PubMed ID: 805046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
